This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrigues, H. J.
Right arrow Articles by Rose, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrigues, H. J.
Right arrow Articles by Rose, T. M.

 Previous Article  |  Next Article 

Journal of Virology, February 2008, p. 1570-1580, Vol. 82, No. 3
0022-538X/08/$08.00+0     doi:10.1128/JVI.01673-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Integrin {alpha}Vβ3 Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor{triangledown}

H. Jacques Garrigues,1 Yelena E. Rubinchikova,1 C. Michael DiPersio,2 and Timothy M. Rose1*

Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98195,1 Center for Cell Biology and Cancer Research, Albany Medical College, Albany, New York 12208-34792

Received 1 August 2007/ Accepted 13 November 2007

Kaposi's sarcoma-associated herpesvirus (KSHV) envelope-associated glycoprotein B (gB) is involved in the initial steps of binding to host cells during KSHV infection. gB contains an RGD motif reported to bind the integrin {alpha}3β1 during virus entry. Although the ligand specificity of {alpha}3β1 has been controversial, current literature indicates that {alpha}3β1 ligand recognition is independent of RGD. We compared {alpha}3β1 to the RGD-binding integrin, {alpha}Vβ3, for binding to envelope-associated gB and a gB(RGD) peptide. Adhesion assays demonstrated that β3-CHO cells overexpressing {alpha}Vβ3 specifically bound gB(RGD), whereas {alpha}3-CHO cells overexpressing {alpha}3β1 did not. Function-blocking antibodies to {alpha}Vβ3 inhibited the adhesion of HT1080 fibrosarcoma cells to gB(RGD), while antibodies to {alpha}3β1 did not. Using affinity-purified integrins and confocal microscopy, {alpha}Vβ3 bound to gB(RGD) and KSHV virions, demonstrating direct receptor-ligand interactions. Specific {alpha}Vβ3 antagonists, including cyclic and dicyclic RGD peptides and {alpha}Vβ3 function-blocking antibodies, inhibited KSHV infection by 70 to 80%. Keratinocytes from {alpha}3-null mice lacking {alpha}3β1 were fully competent for infection by KSHV, and reconstitution of {alpha}3β1 function by transfection with {alpha}3 cDNA reduced KSHV infectivity from 74% to 55%. Additional inhibitory effects of {alpha}3β1 on the cell surface expression of {alpha}Vβ3 and on {alpha}Vβ3-mediated adhesion of {alpha}3-CHO cells overexpressing {alpha}3β1 were detected, consistent with previous reports of transdominant inhibition of {alpha}Vβ3 function by {alpha}3β1. These observations may explain previous reports of an inhibition of KSHV infection by soluble {alpha}3β1. Our studies demonstrate that {alpha}Vβ3 is a cellular receptor mediating both the cell adhesion and entry of KSHV into target cells through binding the virion-associated gB(RGD).


* Corresponding author. Mailing address: Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195. Phone: (206) 616-2084. Fax: (206) 543-3873. E-mail: trose{at}u.washington.edu

{triangledown} Published ahead of print on 28 November 2007.


Journal of Virology, February 2008, p. 1570-1580, Vol. 82, No. 3
0022-538X/08/$08.00+0     doi:10.1128/JVI.01673-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hahn, A., Birkmann, A., Wies, E., Dorer, D., Mahr, K., Sturzl, M., Titgemeyer, F., Neipel, F. (2009). Kaposi's Sarcoma-Associated Herpesvirus gH/gL: Glycoprotein Export and Interaction with Cellular Receptors. J. Virol. 83: 396-407 [Abstract] [Full Text]  
  • Veettil, M. V., Sadagopan, S., Sharma-Walia, N., Wang, F.-Z., Raghu, H., Varga, L., Chandran, B. (2008). Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ({alpha}V{beta}5, {alpha}V{beta}3, and {alpha}3{beta}1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection. J. Virol. 82: 12126-12144 [Abstract] [Full Text]  
  • Qian, L.-W., Greene, W., Ye, F., Gao, S.-J. (2008). Kaposi's Sarcoma-Associated Herpesvirus Disrupts Adherens Junctions and Increases Endothelial Permeability by Inducing Degradation of VE-Cadherin. J. Virol. 82: 11902-11912 [Abstract] [Full Text]  
  • Subramanian, R., D'Auvergne, O., Kong, H., Kousoulas, K. G. (2008). The Cytoplasmic Terminus of Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein B Is Not Essential for Virion Egress and Infectivity. J. Virol. 82: 7144-7154 [Abstract] [Full Text]  
  • Dupuy, A. G., Caron, E. (2008). Integrin-dependent phagocytosis - spreading from microadhesion to new concepts. J. Cell Sci. 121: 1773-1783 [Abstract] [Full Text]  
  • Rappocciolo, G., Hensler, H. R., Jais, M., Reinhart, T. A., Pegu, A., Jenkins, F. J., Rinaldo, C. R. (2008). Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN. J. Virol. 82: 4793-4806 [Abstract] [Full Text]